Quantcast

Latest CIDP Stories

2010-11-05 06:16:00

MADISON, Wis., Nov. 5, 2010 /PRNewswire/ -- Armed with the latest information, physicians can diagnose patients with Guillain-Barre Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP) more easily and earlier, increasing the chances of successful recovery. Thanks to a partnership between Sonic Foundry, Inc. (Nasdaq: SOFO), the recognized market leader for rich media webcasting and knowledge management, and the GBS/CIDP Foundation International, the most recent...

2010-09-15 14:25:00

NARBERTH, Pa., Sept. 15 /PRNewswire/ -- The GBS/CIDP Foundation International will host its eleventh international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in King of Prussia, PA, November 5-7, 2010. Over 400 medical professionals, current and former patients, and caregivers from all over the world are expected to attend the three-day event at the Dolce Hotel - Valley Forge. In addition to general sessions covering the latest...

2010-04-12 10:07:00

RESEARCH TRIANGLE PARK, N.C., April 12 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics, Inc., today announced results of a new survey showing that Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) is the preferred immune globulin intravenous (IGIV) among neurologists who indicated a brand preference. In the survey, conducted online by Harris Interactive® on behalf of Talecris, neurologists selected Gamunex over...

2009-06-10 10:56:57

 New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. Eduardo De Sousa, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Electrodiagnostic Neuromuscular Lab at JHN, led the study which looked at the number of demyelinating features that are needed to differentiate between CIDP, Amyotrophic lateral sclerosis (ALS, or Lou...

2009-04-24 11:01:00

Patients with rare, chronic inflammatory demyelinating polyneuropathy (CIDP) depend on plasma donation ANNAPOLIS, Md., April 24 /PRNewswire/ -- Chronic inflammatory demyelinating polyneuropathy (CIDP) is a debilitating, progressive neurological disorder that results in muscle weakness and fatigue and can severely impair motor skills. According to the GBS/CIDP Foundation International, CIDP affects two to seven individuals per 100,000 worldwide. The rare disease is treated with intravenous...

2008-10-07 09:00:55

NARBERTH, Pa., Oct. 7 /PRNewswire/ -- The GBS/CIDP Foundation International will host its tenth international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Bloomingdale, IL on November 7-9, 2008. Over 250 medical professionals, current and former patients and caregivers from all over the world are expected to attend the three-day event at the Indian Lake Resort. In addition to general sessions covering the latest developments in...

2008-09-23 12:00:13

A study of a treatment for chronic inflammatory demyelinating neuropathy (CIDP) suggests that 50 percent of the patients who responded to treatment with Gamunex (Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified) required two treatments before they first exhibited improvements on a standard disability measurement scale, according to data presented at the American Neurological Association meeting in Salt Lake City, Utah. The study authors concluded that "further...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related